A Borderline TSH in an Older Adult Is Often Just Normal Aging

The short version#

A thyroid-stimulating hormone (TSH) value that sits a little above the printed cutoff, in an older adult who feels well and whose free thyroxine is normal, is frequently a number that is normal for that person's age rather than a sign of thyroid disease. TSH rises naturally across the decades, so comparing an 80-year-old's result to a reference range built mostly from younger adults tilts the interpretation toward a diagnosis that the biology does not support. The correction is not a new test or a prescription. It is reading the same number against an age-matched expectation.

Key points#

• Lab reference ranges are statistical constructs, usually the middle 95 percent of a reference population, not a definition of health.
• The upper edge of the healthy TSH range climbs steadily with age, roughly doubling between young adulthood and the ninth decade.
• Applying one fixed cutoff to everyone converts ordinary age-related drift into a label of subclinical hypothyroidism for many older people.
• Checking free thyroxine (FT4) helps separate genuine early thyroid failure from normal aging better than an isolated TSH does.
• The best trial evidence shows that treating this mild picture with levothyroxine does not relieve symptoms in older adults.

Where a "normal range" actually comes from#

It helps to remember what a reference range is before you decide what a result means. A laboratory does not measure health directly. It samples a reference population, plots the spread of values, and draws lines around the central 95 percent, with the top line usually set at the 97.5th percentile. Everything inside is called normal by convention. Nothing about that line is a biological threshold for disease. It is a description of a crowd.

That matters because the crowd used to set the TSH cutoff skews young. When a range built largely from people in their twenties and thirties is printed on the report of someone in their eighties, the comparison is subtly unfair. The older person is being measured against a younger body's statistics.

What TSH is doing, and why it climbs with age#

TSH is the pituitary gland's instruction to the thyroid: produce more hormone. If the thyroid falls behind, TSH rises to push harder. A raised TSH alongside a normal FT4 is what defines subclinical hypothyroidism, meaning the gland is still delivering enough hormone, but the pituitary is leaning on it a bit more to get there.

The important physiological fact is that this leaning increases with age even in people who never develop thyroid disease. The set point drifts. Large population data make the pattern hard to miss. In an analysis of the U.S. NHANES III survey, Surks and Hollowell found that the whole TSH distribution moves toward higher values as people get older. The 97.5th percentile, the number normally used to draw the upper limit, was about 3.6 mIU/L in adults in their twenties and rose to roughly 7.5 mIU/L in people past 80. The proportion of thyroid-healthy adults with a TSH above 2.5 mIU/L climbed from about 11 percent among the youngest to about 40 percent among the oldest.

The knock-on effect is large. In that same dataset, close to 70 percent of older adults whose TSH landed above the usual 4.5 mIU/L cutoff were in fact within the range that is normal for their own age group. Their result looked abnormal only because it was scored against a younger person's scale.

What changes when the range is matched to age#

This is not a hypothetical concern. A 2022 study by Ni and colleagues in Scientific Reports constructed age-specific TSH ranges for older adults and then counted how many people the label would capture under each method. A standard laboratory cutoff tagged about 10 percent of the older population with subclinical hypothyroidism. Age-specific ranges brought that below 4 percent, and the gap grew with age: in the oldest band, the conventional cutoff flagged nearly 14 percent while the age-matched range flagged under 4 percent. The upper limit that fit the oldest adults sat well above the familiar 4.5 figure. The authors concluded that age-specific ranges can prevent overdiagnosis in older people. Put simply, most of the extra cases generated by a fixed cutoff are an artifact of the ruler, not a signal of disease.

This is the kind of question that runs through a lot of clinical epidemiology, including research on how reference points differ by age and by sex. A value that is unremarkable in one group can look abnormal once you score it against another group's norm, which is exactly why age-stratified and sex-stratified thinking keeps earning its place in diagnosis.

The sharper objection: do not just move the line#

There is a serious counterargument. A 2022 study by Abbey, Mammen, and colleagues in Frontiers in Endocrinology argued that sliding the TSH cutoff by age is a statistical fix that skips over the biology. A mildly raised TSH in an older adult can mean one of two very different things: harmless age-related drift, or the earliest stage of a genuinely failing thyroid. Simply raising the threshold treats both the same and risks waving through a real problem.

Their proposal was to stop relying on TSH alone and look at FT4, the actual hormone in circulation. In their analysis, a low-normal FT4 helped flag the people whose thyroid was truly starting to fail, separating them from those merely showing the changes of aging. The takeaway is not that age adjustment is wrong. It is that an isolated high TSH is a thin basis for any diagnosis, and the second hormone on the panel carries information the first one hides from you.

Why the label is not harmless#

If a mildly raised TSH in an older adult seldom reflects disease, the real stakes lie in what the label triggers, which is usually a prescription. On that point the trial evidence is unusually clean. The TRUST trial, reported in the New England Journal of Medicine in 2017, randomly assigned adults aged 65 and older with subclinical hypothyroidism to levothyroxine or placebo. The medication lowered TSH as designed, but it produced no improvement in thyroid-related symptoms or tiredness over placebo. Later pooled and extended analyses reached the same conclusion, including among adults past 80.

So the chain has real weight. A young person's reference range, laid over an older body, turns ordinary aging into a diagnosis, and that diagnosis often leads to lifelong medication that the strongest trials show does not help the very people a fixed cutoff is most likely to catch. This is also why screening bodies counsel restraint. The U.S. Preventive Services Task Force found insufficient evidence to recommend routine thyroid screening in asymptomatic nonpregnant adults, and it treated false-positive labeling as a harm in its own right.

Reading your own result#

None of this argues for ignoring a high TSH. Overt hypothyroidism, real symptoms, pregnancy, and markedly elevated values are separate situations that deserve prompt attention. The narrow point is this: a TSH modestly over a fixed cutoff, in an older adult who feels well and whose FT4 is normal, is often a number that is normal for that age rather than proof of a failing thyroid. If that describes your result, a sensible response is usually to check FT4, to repeat the test before anyone acts on a single value, and to interpret the number against an age-appropriate expectation. A reference range is where your conversation starts, not where it ends.